RYTM Rhythm Pharmaceuticals, Inc.
88.45USD-2.56%Mkt Cap: 6.07B $P/E: —1d ago
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally. The company's lead product candidate is IMCIVREE (setmelan…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.27BUSDP/E 30.7
$22.99BUSDP/E 14.5
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap6.07B USD
Enterprise Value6.14B USD
Revenue (TTM)239.92M USD
Gross Profit170.26M USD
Net Income (TTM)-196.54M USD
Revenue/Share3.56 USD
Last Price88.45 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees414
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-148.17
PEG—
EV/EBITDA-30.78
EV/Revenue25.60
P/S25.95
P/B60.68
EPS (TTM)-3.12
EPS (Forward)-0.61
52W Range
74.5029% of range122.20
52W High122.20 USD
52W Low74.50 USD
Profitability
Gross Margin89.73%
Oper. Margin-68.14%
EBITDA Margin-83.17%
Profit Margin-103.57%
ROE-72.79%
ROA-40.93%
Growth
Revenue Growth46.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-115.67M USD
CapEx (TTM)953.00K USD
FCF Margin-54.43%
FCF Yield-2.15%
Net Debt-221.11M USD
Net Debt/EBITDA1.11
Balance Sheet
Debt/Equity0.01
Current Ratio3.45
Quick Ratio3.00
Book Value/Sh1.50 USD
Cash/Share4.81 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)138.59 USD
Upside (mean)+56.7%
Target Range105.00 USD – 160.00 USD
105.00+56.7% to mean160.00
# Analysts17
Ownership
Shares Out.68.59M
Float56.04M
Insiders0.70%
Institutions114.84%
Short Interest
Short Ratio20.6d
Short % Float15.06%
Short % Out.14.94%
Shares Short10.29M
Short (prev mo.)10.15M
Technical
SMA 50105.22 (-15.9%)
SMA 20098.79 (-10.5%)
Beta2.01
S&P 52W Chg16.45%
Avg Vol (30d)614.12K
Avg Vol (10d)761.82K
Technical Indicators
RSI (14)24.3
MACD-4.0860
MACD Signal-3.3368
MACD Hist.-0.7492
BB Upper106.32 USD
BB Middle97.57 USD
BB Lower88.81 USD
BB Width17.95%
ATR (14)3.916 USD
Vol Ratio (20d)1.18x